SpringWorks Therapeutics Inc (SWTX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

100 WASHINGTON BOULEVARD STAMFORD, CT 06902

SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. SpringWorks has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers. SpringWorks' strategic approach and operational excellence in clinical development have enabled it to rapidly advance its two lead product candidates into late-stage clinical trials while simultaneously entering into multiple shared-value partnerships with industry leaders to expand its portfolio.

Data as of 2021-08-02 09:07:42 -0400
Market Cap4.205 Billion Shares Outstanding49.061 Million Avg 30-day Volume204.416 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-2.47 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.02814 52-week High/Low96.48 / 36.71 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -135.4965
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from SWTX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 6 7 -14.29% 4 (0.23%) 5 (0.29%) -20.0%
Funds Holding: 136 124 9.68% 49 (2.88%) 47 (2.73%) 4.26%
13F shares: 43.415 Million 43.322 Million 0.22% 21.078 Million 21.221 Million -0.68%
% Ownership 88.645 88.8337 -0.21% 43.0365 43.5157 -1.1%
New Positions: 25 39 -35.9% 11 15 -26.67%
Increased Positions 51 55 -7.27% 19 19 0.0%
Closed Positions 13 7 85.71% 9 3 200.0%
Reduced Positions 45 16 181.25% 15 9 66.67%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SWTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SWTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

262.5 Thousand total shares from 13 transactions

Exercise Derivative Conversion (M)

10 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ISLAM SAQIB CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
821,552 2021-07-19 4

SMITH L. MARY CHIEF DEVELOPMENT OFFICER

  • Officer
261,807 2021-07-13 4

EDRIS BADREDDIN CHIEF OPERATING OFFICER

  • Officer
301,541 2021-07-01 3

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

  • 10% Owner
6,028,307 2021-07-01 6

BURGESS MICHAEL F. HEAD OF RESEARCH & DEVELOPMENT

  • Officer
252,500 2021-06-01 2

SQUINTO STEPHEN P

  • Director
  • 10% Owner
6,320,139 2021-05-20 3

SCHWARTZ JEFFREY LAWRENCE

  • Director
  • 10% Owner
5,839,411 2021-05-20 1

HAMBLETON JULIE

  • Director
12,993 2021-05-20 1

LEWIS-HALL FREDA C

  • Director
32,225 2021-05-20 1

LYNCH DANIEL

  • Director
299,381 2021-05-20 2

FUHRMAN ALAN

  • Director
32,225 2021-05-20 1

ASHAR BHAVESH CHIEF COMMERCIAL OFFICER

  • Officer
104,500 2021-04-01 2

BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC

BC SW, LP

SCHWARTZ JEFFREY LAWRENCE

KOPPEL ADAM

  • Director
  • 10% Owner
5,831,307 2021-03-09 1

WEINSTEIN HERSCHEL S GENERAL COUNSEL AND SECRETARY

  • Officer
7,000 2021-01-07 1

RENSTRUP JENS CHIEF MEDICAL OFFICER

  • Officer
250,499 2021-01-07 1

FRANCIS PERIER I JR CHIEF FINANCIAL OFFICER

  • Officer
10,000 2021-01-07 1

PICHL DANIEL CHIEF PEOPLE OFFICER

  • Officer
4,150 2021-01-07 1

NOFI MICHAEL CHIEF ACCOUNTING OFFICER

  • Officer
3,000 2021-01-07 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ISLAM SAQIB - Director - Officer CHIEF EXECUTIVE OFFICER

2021-07-20 19:34:13 -0400 2021-07-20 S 18,572 $77.68 d 821,552 direct yes -1.2882 5.5863 5.5863 6 -1.2882 2

ISLAM SAQIB - Director - Officer CHIEF EXECUTIVE OFFICER

2021-07-20 19:34:13 -0400 2021-07-19 S 43,928 $76.09 d 840,124 direct yes -1.2882 5.5863 5.5863 6 -1.2882 2

SMITH L. MARY - Officer CHIEF DEVELOPMENT OFFICER

2021-07-14 16:28:33 -0400 2021-07-13 S 10,000 $80.88 d 167,511 direct yes -0.3846 5.1019 6.4735 5 -2.4997 3

SMITH L. MARY - Officer CHIEF DEVELOPMENT OFFICER

2021-07-14 16:28:33 -0400 2021-07-13 M 10,000 $2.30 a 177,511 direct yes -0.3846 5.1019 6.4735 5 -2.4997 3

SMITH L. MARY - Officer CHIEF DEVELOPMENT OFFICER

2021-07-14 16:28:33 -0400 2021-07-13 M 10,000 d 94,296 direct yes

EDRIS BADREDDIN - Officer CHIEF OPERATING OFFICER

2021-07-01 18:30:12 -0400 2021-07-01 S 32,000 $85.35 d 301,541 direct yes -2.7049 -3.2041 0.0 1 -4.632 4

ORBIMED ADVISORS LLC - > 10% Owner see footnotes

ORBIMED CAPITAL GP VI LLC - > 10% Owner see footnotes

2021-07-06 16:42:46 -0400 2021-07-01 S 15,959 $85.01 d 6,028,307 indirect -1.6168 -5.521 0.5269 3 -5.521 6

ORBIMED ADVISORS LLC - > 10% Owner see footnotes

ORBIMED CAPITAL GP VI LLC - > 10% Owner see footnotes

2021-06-30 21:01:24 -0400 2021-06-28 S 6,502 $85.17 d 6,044,266 indirect -0.6344 -3.1722 0.0 1 -5.2371 5

ORBIMED ADVISORS LLC - > 10% Owner see footnotes

ORBIMED CAPITAL GP VI LLC - > 10% Owner see footnotes

2021-06-25 19:11:35 -0400 2021-06-25 S 22,334 $85.14 d 6,050,768 indirect -4.2974 1.1709 4.6475 4 -4.2974 2

ORBIMED ADVISORS LLC - > 10% Owner see footnotes

ORBIMED CAPITAL GP VI LLC - > 10% Owner see footnotes

2021-06-25 19:11:35 -0400 2021-06-24 S 34,200 $85.22 d 6,073,102 indirect -4.2974 1.1709 4.6475 4 -4.2974 2

ORBIMED ADVISORS LLC - > 10% Owner see footnotes

ORBIMED CAPITAL GP VI LLC - > 10% Owner see footnotes

2021-06-25 19:11:35 -0400 2021-06-23 S 100 $85.00 d 6,107,302 indirect -4.2974 1.1709 4.6475 4 -4.2974 2

ORBIMED ADVISORS LLC - > 10% Owner see footnotes

ORBIMED CAPITAL GP VI LLC - > 10% Owner see footnotes

2021-06-14 17:58:20 -0400 2021-06-10 S 30,852 $85.09 d 6,107,402 indirect -0.0377 4.6185 10.0653 10.0653 31 -4.5432 24

ORBIMED ADVISORS LLC - > 10% Owner see footnotes

ORBIMED CAPITAL GP VI LLC - > 10% Owner see footnotes

2021-06-09 18:26:45 -0400 2021-06-09 S 5,049 $85.33 d 6,138,254 indirect -2.0841 -5.502 -1.1671 3.2393 16 -9.42 27

ORBIMED ADVISORS LLC - > 10% Owner see footnotes

ORBIMED CAPITAL GP VI LLC - > 10% Owner see footnotes

2021-06-09 18:26:45 -0400 2021-06-08 S 42,633 $85.37 d 6,143,303 indirect -2.0841 -5.502 -1.1671 3.2393 16 -9.42 27

ORBIMED ADVISORS LLC - > 10% Owner see footnotes

ORBIMED CAPITAL GP VI LLC - > 10% Owner see footnotes

2021-06-09 18:26:45 -0400 2021-06-07 S 371 $84.90 d 6,185,936 indirect -2.0841 -5.502 -1.1671 3.2393 16 -9.42 27

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 22:15:03 UTC -0.3319 0.3919 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 21:45:03 UTC -0.3319 0.3919 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 21:15:03 UTC -0.3319 0.3919 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 20:45:03 UTC -0.3319 0.3919 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 20:15:03 UTC -0.3319 0.3919 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 19:45:03 UTC -0.3319 0.3919 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 19:15:03 UTC -0.3319 0.3919 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 18:45:03 UTC -0.3319 0.3919 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 18:15:03 UTC -0.3319 0.3919 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 17:45:03 UTC -0.3319 0.3919 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 17:15:03 UTC -0.3319 0.3919 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 16:45:03 UTC -0.3065 0.3865 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 16:15:03 UTC -0.3065 0.3865 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 15:45:03 UTC -0.3065 0.3865 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 15:15:03 UTC -0.3065 0.3865 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 14:45:03 UTC -0.17 0.25 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 14:15:03 UTC -0.17 0.25 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 13:45:03 UTC -0.17 0.25 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 13:15:04 UTC -0.17 0.25 150000
SPRINGWORKS THERAPEUTICS INC SWTX 2021-08-02 12:45:03 UTC -0.17 0.25 150000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund SWTX -7.0 shares, $-189.0 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund SWTX -6.0 shares, $-162.0 2020-03-31 N-PORT

Elevate your investments